American Society of Hematology

Hematologic Drug Shortage Information


Updated on: August 02, 2019

ASH continues to work with Congress, federal agencies, and other stakeholders to ensure continued access to safe and effective hematologic drugs.

New Updates on Hematologic Drug Shortages

National Shortage of Intravenous Immune Globulin (IVIG)

ASH members are concerned about the national shortage of intravenous immune globulin (IVIG). The Society has contacted the U.S. Food and Drug Administration’s (FDA) Drug Shortage Office and Office of Compliance and Biologics Quality regarding the critical nature of this shortage. The FDA is directing all questions to individual manufacturers to resolve the shortage; Manufacturers’ contact information can be found online. ASH continues to monitor this shortage, and ASH members who are dealing with a critical case that requires this therapy and are encountering access issues should contact Policy and Practice Coordinator, Katherine Stark

 

 

For more information or to notify ASH of drug recalls or shortages, please contact Katherine Stark at kstark@hematology.org

back to top

Recent Hematologic Drug Shortages

back to top

Current Hematologic Drug Shortages

back to top

Discontinued Hematologic Drugs

back to top

Recently Resolved Hematologic Drug Shortages

back to top

Additional Resources

back to top

ASH's Comments to Congress and the U.S. Food and Drug Administration

back to top

Media Coverage of Drug Shortages

back to top